About Depixus
Depixus is a Healthcare company based in Paris (France) founded in 2012 by Gordon Hamilton. Single-molecule genetic and epigenetic sequencing solutions are provided. Depixus has raised $34.52 million across 5 funding rounds from investors including Bpifrance, European Union and Arix Bioscience. Its chief executive, as recorded, is Gordon Hamilton. Depixus offers products and services including MAGNA One. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.
Company details
Depixus was founded in 2012 and is based in Paris, France, within the biotechnology sector. Solutions for single-molecule genetic and epigenetic sequencing are offered through the SIMDEQ platform technology. This technology, originally developed at École Normale Supérieure, relies on biophysical properties of DNA and RNA. Hairpin libraries are created from DNA and RNA, immobilized on magnetic beads, and manipulated by magnetic fields to enable zipping and unzipping processes for analysis.
- Headquarters Paris, France
- Founders Gordon Hamilton
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website depixus.com
- Social LinkedIn X YouTube
- Total Equity Funding$34.52M (USD)
in 5 rounds
- Latest Funding Round$34.52M (USD), Series A
Dec 2021
- InvestorsBpifrance
& 5 more
Products & Services of Depixus
Depixus offers a comprehensive portfolio of products and services, including MAGNA One.
Platform for real-time analysis of biomolecular interactions in research.
Apps and channels of Depixus
its YouTube channel Depixus has 14 subscribers and 9 videos.
Videos from Depixus
The most watched videos on Depixus's YouTube channel, Depixus (14 subscribers). Click a video to play it here.
More on Depixus.
Funding Insights of Depixus
Depixus has successfully raised a total of $34.52M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $34.52 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.52M
- Total Rounds 5
- Last Round Series A — $34.52M
- Investors Count 6
All 5 funding rounds of Depixus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $34.52M | Series A | – | Lansdowne Partners, Bpifrance | |
| Oct 2021 | $115,607 | Grant | – | – | |
| Nov 2018 | $2.33M | Grant | – | – | |
| Dec 2016 | $52,678 | Grant | – | – | |
| Jul 2016 | Series A | – | – |
6 investors in total: 6 institutional.
Investors in Depixus
Depixus has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Bpifrance, European Union and Arix Bioscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investing in Life Sciences sectors like Healthcare and Biotechnology. | casdincapital.com | |||
Investments in biotech startups are made by Arix Bioscience. | 2016 | arixbioscience.com | London, United Kingdom | |
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Offers fundamental equity investing and management for institutional clients since 1998. | 1998 | lansdownepartners.com | London, United Kingdom | |
Corporate consultancy, advisory, and funding services are provided to businesses. | 2012 | bpifrance.com | Maisons Alfort, France | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Depixus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Depixus
30 people are tracked at Depixus (7 in leadership, 5 in board & advisors, 18 in team).
| Name | Role | Group |
|---|---|---|
Gordon Hamilton | Co-Founder & CEO | Leadership |
Jimmy Ouellet | Chief Scientist | Leadership |
Nigel Skinner | Marketing Director | Leadership |
Pascale Beurdeley | Senior Vice President Of Product Development | Leadership |
Thibault VIEILLE | VP of Engineering | Leadership |
Isabelle Belanger-Basset | Software Director | Leadership |
Steve Klose | Chief Commercial Officer (cco) | Leadership |
John Berriman | Chair | Board & advisors |
Ronald Lindsay | Board Member | Board & advisors |
Mark Chin | Board Member | Board & advisors |
Lachlan MacKinnon | Board Member | Board & advisors |
Thibault Roulon | Board Member | Board & advisors |
Zhanna Kaimedenova | Frontend Engineer | Team |
Cecilia De Araujo-Loriot | R&D Senior Scientist | Team |
Steve Allen | CBO & Board Member | Team |
Milan Tair | Senior Back-End Software Developer | Team |
Jérôme Maluenda | Scientist | Team |
Henning Labuhn | Senior Data & AI Scientist | Team |
Christelle Taochy | R&D molecular biology scientist | Team |
David Salthouse | Data Scientist | Team |
10 more people are available in the full profile.
Complete people profiles for Depixus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Depixus
3 dated milestones of Depixus across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Depixus is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $34.5M.
Web traffic of Depixus
The website of Depixus (depixus.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 22.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Depixus
Complete news archive for Depixus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Depixus
Depixus was founded in 2012 and raised its 1st funding round 4 years after it was founded.
Depixus is headquartered in Paris, France.
Gordon Hamilton is the CEO of Depixus, as recorded in our data. They have also founded this company.
Depixus is a funded company, having raised a total of $34.52M across 5 funding rounds to date.
Depixus was founded in 2012 and is based in Paris, France, within the biotechnology sector. Solutions for single-molecule genetic and epigenetic sequencing are offered through the SIMDEQ platform technology. This technology, originally developed at École Normale Supérieure, relies on biophysical properties of DNA and RNA. Hairpin libraries are created from DNA and RNA, immobilized on magnetic beads, and manipulated by magnetic fields to enable zipping and unzipping processes for analysis.
Depixus offers MAGNA One.
Depixus has 6 investors. Key investors include Bpifrance, European Union, Arix Bioscience, Lansdowne Partners, and Casdin Capital.